Review
doi: 10.1006/biol.1995.0026.
Poxvirus-based vectors as vaccine candidates
Affiliations
- PMID: 7546658
- DOI: 10.1006/biol.1995.0026
Item in Clipboard
Review
Poxvirus-based vectors as vaccine candidates
Biologicals.
1995 Jun.
Abstract
The safety issues surrounding the use of vaccinia-based vaccine candidates have been significantly addressed with the development of the NYVAC and ALVAC vectors. These vectors can be engineered to express multiple genes from the same pathogen or multiple genes from multiple pathogens. The use of these vectors to develop needed vaccines for human and veterinary medicine remains the focus of studies that are currently in progress.
Similar articles
-
Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVAC.Dev Biol Stand. 1995;84:159-63. Dev Biol Stand. 1995. PMID: 7796949 Review.
-
Safe and effective poxvirus vectors--NYVAC and ALVAC.Dev Biol Stand. 1994;82:65-9. Dev Biol Stand. 1994. PMID: 7958484 Review.
-
Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B.Vaccine. 2007 Apr 12;25(15):2863-85. doi: 10.1016/j.vaccine.2006.09.090. Epub 2006 Oct 16. Vaccine. 2007. PMID: 17113200
-
Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs.Vaccine. 2009 Apr 6;27(16):2258-64. doi: 10.1016/j.vaccine.2009.02.006. Epub 2009 Feb 12. Vaccine. 2009. PMID: 19428840
-
Poxviruses as vaccine vectors.Comp Immunol Microbiol Infect Dis. 2003 Oct;26(5-6):343-55. doi: 10.1016/S0147-9571(03)00019-5. Comp Immunol Microbiol Infect Dis. 2003. PMID: 12818621 Review.
Cited by
-
Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene.J Virol. 2006 Jun;80(12):6033-47. doi: 10.1128/JVI.02108-05. J Virol. 2006. PMID: 16731942 Free PMC article.
-
Direct comparison of antigen production and induction of apoptosis by canarypox virus- and modified vaccinia virus ankara-human immunodeficiency virus vaccine vectors.J Virol. 2007 Jul;81(13):7022-33. doi: 10.1128/JVI.02654-06. Epub 2007 Apr 4. J Virol. 2007. PMID: 17409140 Free PMC article.
-
Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates.J Virol. 2018 Mar 28;92(8):e02035-17. doi: 10.1128/JVI.02035-17. Print 2018 Apr 15. J Virol. 2018. PMID: 29437967 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
